Log In
Print this Print this

NIAID/GSK Ebola vaccine

Also known as: VRC-EBOADC069-00-VP

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionChimpanzee-derived replication-defective adenovirus (ChAd) vaccine expressing Ebola antigens
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationEbola
Indication Details 
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today